Companies · Other Health Care
RENTON · Other Health Care
Diligence memoA one-page analyst read on Tegria RCM Group - US, Inc. — recommendation, valuation, rhythm, risks.→Tegria RCM Group - US, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Tegria RCM Group - US, Inc. is one of 5377 Other Health Care companies tracked from RENTON. By capital raised it ranks in the upper tier (ahead of 78% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 78% of sector peers (real $). Modeled value above 10% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #190 of 196.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| CareHarmony, Inc. | Series A | $17.4M | $145.2M | 3.96× |
| Dragonfly Endoscopy Inc. | Series A | $12.7M | $142.0M | 3.87× |
| NuvoAir Holdings, Inc. | Series A | $10.7M | $125.1M | 3.41× |
| Post Acute Recovery, Inc. | Series A | $14.5M | $123.0M | 3.35× |
| Micro Interventional Devices, Inc. | Series A | $14.0M | $119.0M | 3.25× |
| Etiometry Inc. | Series A | $15.6M | $114.7M | 3.13× |
| SafKan, Inc. | Series A | $13.0M | $108.5M | 2.96× |
| BehaVR Holdings, Inc. | Series A | $12.1M | $102.1M | 2.78× |
| Outliers Inc. | Series A | $13.6M | $101.7M | 2.77× |
| RevMedica, Inc. | Series A | $14.2M | $101.2M | 2.76× |
| Innovoyce LLC | Series A | $9.9M | $97.6M | 2.66× |
| Prixz, Inc. | Series A | $9.2M | $97.4M | 2.66× |
| Tegria RCM Group - US, Inc. this company | Series A | $11.8M | $2.0M | 0.06× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $6.7M | 2021-09-13 | $30.6M | $88.3M | 90% |
| Series A | $4.8M | 2021-10-04 | $22.0M | $62.3M | 90% |
| Series A | $227K | 2022-09-30 | $1.0M | $2.0M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| John Whipple | — | 1 other | 2021-09 |
| Paul George | — | 1 other | 2021-09 |
| Dan Rieber | — | — | 2021-09 |
| Kevin Manemann | — | — | 2021-09 |
| Lincoln Popp | — | — | 2021-09 |
| Sandra Andrews | — | — | 2021-09 |
Tegria RCM Group - US, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Tegria Services Group, Inc. | Other Health Care | Series A | $10.8M | $7.6M | network2 shared operators · same sector · same stage |
| Wellist, Inc. | Other Health Care | Series A | $12.8M | $1.3M | same sector · same stage |
| Assure Holdings Corp. | Other Health Care | Series A | $13.1M | $2.6M | same sector · same stage |
| RF Surgical Systems, Inc | Other Health Care | Series A | $14.6M | $2.4M | same sector · same stage |
| Theravida, Inc. | Other Health Care | Series A | $9.1M | $1.6M | same sector · same stage |
| South Campus Surgery Center Llc | Other Health Care | Series A | $15.3M | $1.8M | same sector · same stage |
| Inspire Veterinary Partners, Inc. | Other Health Care | Series A | $8.9M | $1.2M | same sector · same stage |
| Momtech Inc. | Other Health Care | Series A | $7.9M | $2.2M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Tegria Services Group, Inc. | Other Health Care | Series A | $7.6M | 95% |
| tEMed Holdings LLC | Other Health Care | Series A | $121.1M | 86% |
| TegoSens, Inc. | Other Health Care | Seed | $35.5M | 86% |
| Teckro, Inc. | Other Health Care | Series B | $366.4M | 85% |
| Tetricus Inc. | Other Health Care | Pre-Seed | $2.7M | 84% |
| MedVirginia, Inc. | Other Health Care | Seed | $12.4M | 84% |
| TecTraum, Inc. | Other Health Care | Seed | $36.7M | 83% |
| TETmedical, Inc. | Other Health Care | Seed | $17.5M | 83% |
See where Tegria RCM Group - US, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Tegria RCM Group - US, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.